Oslo, 13 November 2012 - PCI Biotech (PCIB) has entered into a Market Maker agreement with Fondsfinans ASA.
Fondsfinans ASA will from 14 November 2012 quote bid and ask prices in the share in accordance with guidelines provided by the Oslo Stock Exchange.
The purpose of the agreement is to increase the trading liquidity of the PCI Biotech share.
For further information, please contact:
Bernt-Olav Røttingsnes
CFO/IRO
Email: bor@pcibiotech.no
Mobile +47 913 47 021
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.